Anhui Huaren Health Pharmaceutical Co., Ltd.

Equities

301408

CNE100005YT4

Drug Retailers

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
12.64 CNY -1.56% Intraday chart for Anhui Huaren Health Pharmaceutical Co., Ltd. +1.53% -20.75%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Anhui Huaren Health Pharmaceutical Co., Ltd. Approves the Election of Independent Directors CI
Certain A Shares of Anhui Huaren Health Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 2-MAR-2024. CI
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Anhui Huaren Health Pharmaceutical Co., Ltd.(XSEC:301408) added to S&P Global BMI Index CI
Anhui Huaren Health Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Anhui Huaren Health Pharmaceutical Co., Ltd. completed the acquisition of Jiangsu Shenhua Pharmaceutical Co., Ltd. from Full Health (Hong Kong) Limited. CI
Anhui Huaren Health Pharmaceutical Co., Ltd. signed a letter of intent to acquire 60% stake in Zhoushan Liken Pharmaceutical Chain Co Ltd from Wang Xiangan and Zhejiang Free Trade Zone Xueyuan Project Investment Partnership for approximately CNY 110 million. CI
Anhui Huaren Health Pharma to Buy Smaller Peer For 347 Million Yuan MT
Anhui Huaren Health Pharmaceutical Co., Ltd. signed an agreement to acquire Jiangsu Shenhua Pharmaceutical Co., Ltd. from Full Health (Hong Kong) Limited for approximately CNY 350 million. CI
Huaren Health Pharma Unit Gets Drug Production License MT
Anhui Huaren Health Pharmaceutical Co., Ltd. Elects Yang Ce as A Non-Independent Director CI
Chart Anhui Huaren Health Pharmaceutical Co., Ltd.
More charts
Anhui Huaren Health Pharmaceutical Co Ltd is a China-based company mainly engaged in pharmaceutical retail, agency and terminal centralized procurement business. The pharmaceutical retail business is mainly engaged in the sales of medicines, health food and medical equipment, as well as the diagnosis and treatment of common diseases. The agency business mainly promotes and sells to downstream pharmaceutical retail enterprises. The terminal centralized procurement business mainly provides one-stop distribution services for individual pharmacies and small chain retail terminals.
More about the company